These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8759519)

  • 1. Inhibition of cataracts in moderately diabetic rats by aminoguanidine.
    Swamy-Mruthinti S; Green K; Abraham EC
    Exp Eye Res; 1996 May; 62(5):505-10. PubMed ID: 8759519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of carnosine, aminoguanidine, and aspirin drops on the prevention of cataracts in diabetic rats.
    Yan H; Guo Y; Zhang J; Ding Z; Ha W; Harding JJ
    Mol Vis; 2008; 14():2282-91. PubMed ID: 19081783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
    Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
    Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of a glycemic threshold for the development of cataracts in diabetic rats.
    Swamy-Mruthinti S; Shaw SM; Zhao HR; Green K; Abraham EC
    Curr Eye Res; 1999 Jun; 18(6):423-9. PubMed ID: 10435829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical detection of glycated beta- and gamma-crystallins in lens and their circulating autoantibodies (IgG) in streptozocin induced diabetic rat.
    Ranjan M; Nayak S; Rao BS
    Mol Vis; 2006 Sep; 12():1077-85. PubMed ID: 17093392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical evidence for increased formation of advanced glycation end products and inhibition by aminoguanidine in diabetic rat lenses.
    Matsumoto K; Ikeda K; Horiuchi S; Zhao H; Abraham EC
    Biochem Biophys Res Commun; 1997 Dec; 241(2):352-4. PubMed ID: 9425275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
    Huang Y; Lin S; Zhou J
    Chin Med J (Engl); 1998 Aug; 111(8):698-704. PubMed ID: 11245022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protective effect of aminoguanidine on erectile function in diabetic rats is not related to the timing of treatment.
    Usta MF; Bivalacqua TJ; Koksal IT; Toptas B; Surmen S; Hellstrom WJ
    BJU Int; 2004 Aug; 94(3):429-32. PubMed ID: 15291881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Black and green teas equally inhibit diabetic cataracts in a streptozotocin-induced rat model of diabetes.
    Vinson JA; Zhang J
    J Agric Food Chem; 2005 May; 53(9):3710-3. PubMed ID: 15853424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renoprotective effects of a novel inhibitor of advanced glycation.
    Forbes JM; Soulis T; Thallas V; Panagiotopoulos S; Long DM; Vasan S; Wagle D; Jerums G; Cooper ME
    Diabetologia; 2001 Jan; 44(1):108-14. PubMed ID: 11206401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the intervening mechanism of taurine on streptozotocin-induced diabetic cataracts].
    Song XD; Chen CZ; Dong B; Shi YY; Zhang W; Yan LS; Luo GA
    Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):605-9. PubMed ID: 14766075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes.
    Chang KC; Tseng CD; Wu MS; Liang JT; Tsai MS; Cho YL; Tseng YZ
    Eur J Clin Invest; 2006 Aug; 36(8):528-35. PubMed ID: 16893374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scheimpflug densitometric analysis of cataracts in diabetic rats: correlation with glycation.
    Swamy-Mruthinti S; Green K; Abraham EC
    Ophthalmic Res; 1996; 28(4):230-6. PubMed ID: 8878186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
    Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of putative anti-cataract agents in the prevention of protein glycation.
    Stevens A
    J Am Optom Assoc; 1995 Dec; 66(12):744-9. PubMed ID: 8557952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the pyridoindole antioxidant stobadine on development of experimental diabetic cataract and on lens protein oxidation in rats: comparison with vitamin E and BHT.
    Kyselova Z; Gajdosik A; Gajdosikova A; Ulicna O; Mihalova D; Karasu C; Stefek M
    Mol Vis; 2005 Jan; 11():56-65. PubMed ID: 15682043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of RAGE in aminoguanidine-induced suppression of venous intimal hyperplasia in diabetic rats.
    Wang X; Diao Y; Zhang H; Huo X; Zhang Q
    Ann Vasc Surg; 2009 Mar; 23(2):246-54. PubMed ID: 19110400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats.
    Suryanarayana P; Saraswat M; Petrash JM; Reddy GB
    Mol Vis; 2007 Jul; 13():1291-7. PubMed ID: 17679931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of lens crystallin glycation and high molecular weight aggregate formation by aspirin in vitro and in vivo.
    Swamy MS; Abraham EC
    Invest Ophthalmol Vis Sci; 1989 Jun; 30(6):1120-6. PubMed ID: 2525117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of advanced glycation end products by aminoguanidine restores mast cell numbers and reactivity in alloxan-diabetic rats.
    Carvalho VF; Florim LT; de O Barreto E; Torres RC; Batista MM; Amendoeira FC; Cordeiro RS; Martins MA; E Silva PM
    Eur J Pharmacol; 2011 Nov; 669(1-3):143-8. PubMed ID: 21864526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.